Hiroko Ishibashi

Author PubWeight™ 17.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush. Microbiol Immunol 2003 1.11
2 Suppression of tumor necrosis factor-alpha-induced neutrophil adherence responses by essential oils. Mediators Inflamm 2003 1.02
3 [Anti-Candida albicans activity of essential oils including Lemongrass (Cymbopogon citratus) oil and its component, citral]. Nihon Ishinkin Gakkai Zasshi 2003 0.94
4 Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil. Mediators Inflamm 2006 0.93
5 Suppression of neutrophil accumulation in mice by cutaneous application of geranium essential oil. J Inflamm (Lond) 2005 0.92
6 Oral lactoferrin treatment of experimental oral candidiasis in mice. Antimicrob Agents Chemother 2003 0.91
7 A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model. FEMS Microbiol Lett 2012 0.87
8 Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice. Biol Pharm Bull 2008 0.86
9 Protective effects of farnesol against oral candidiasis in mice. Microbiol Immunol 2008 0.85
10 Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 2004 0.84
11 Effects of the antlered form of Ganoderma lucidum on tumor growth and metastasis in cyclophosphamide-treated mice. Biosci Biotechnol Biochem 2008 0.84
12 Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice. J Infect Chemother 2007 0.83
13 The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis. Biol Pharm Bull 2012 0.81
14 Anti-tumor activities of the antlered form of Ganoderma lucidum in allogeneic and syngeneic tumor-bearing mice. Biosci Biotechnol Biochem 2006 0.80
15 [Therapeutic effect of oligonol, a low-molecular polyphenol formulation derived from lychee fruits on murine oral candidiasis]. Nihon Ishinkin Gakkai Zasshi 2010 0.79
16 Therapeutic effects on murine oral candidiasis by oral administration of cassia (Cinnamomum cassia) preparation. Nihon Ishinkin Gakkai Zasshi 2010 0.78
17 Augmented inhibition of Candida albicans growth by murine neutrophils in the presence of a tryptophan metabolite, picolinic acid. J Infect Chemother 2004 0.78
18 Protection of oral or intestinal candidiasis in mice by oral or intragastric administration of herbal food, clove (Syzygium aromaticum). Nihon Ishinkin Gakkai Zasshi 2005 0.77
19 [Soothing effect of Ganoderma lucidum antlered form on cyclophosphamide-induced adverse reaction]. Gan To Kagaku Ryoho 2005 0.77
20 Production of anti-Candida antibodies in mice with gut colonization of Candida albicans. Mediators Inflamm 2004 0.77
21 Pathological analysis of the Candida albicans-infected tongue tissues of a murine oral candidiasis model in the early infection stage. Arch Oral Biol 2012 0.76
22 Oral candidiasis deteriorated by local application of a glucocorticoid-containing film in a mouse model. Biol Pharm Bull 2008 0.76
23 [A study for testing the antifungal susceptibility of yeast by the Japanese Society for Medical Mycology (JSMM) method. The proposal of the modified JSMM method 2009]. Nihon Ishinkin Gakkai Zasshi 2010 0.75
24 A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid. Med Mycol 2007 0.75
25 [Prophylactic efficacy of a basidiomycetes preparation AHCC against lethal Candida albicans infection in experimental granulocytopenic mice]. Nihon Ishinkin Gakkai Zasshi 2003 0.75
26 [Pharmacological, pharmacokinetic, and clinical profile of itraconazole oral solution (ITRIZOLE Oral Solution 1%)]. Nihon Yakurigaku Zasshi 2007 0.75